Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
about
Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 CloneA new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131Population-based epidemiology and microbiology of community-onset bloodstream infectionsSslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans ModelThe Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.Development of a web tool for Escherichia coli sub-typing based on fimH alleles.MALDI-TOF mass spectrometry as a tool for the discrimination of high-risk Escherichia coli clones from phylogenetic groups B2 (ST131) and D (ST69, ST405, ST393).Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid.The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).Escherichia coli ST131, an intriguing clonal groupGlobal incidence of carbapenemase-producing Escherichia coli ST131.Whole genome sequencing in clinical and public health microbiology.The rpoS gene is predominantly inactivated during laboratory storage and undergoes source-sink evolution in Escherichia coli species.Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.Molecular features of community-associated extended-spectrum-β-lactamase-producing Escherichia coli strains in the United States.Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.Plasmid flux in Escherichia coli ST131 sublineages, analyzed by plasmid constellation network (PLACNET), a new method for plasmid reconstruction from whole genome sequences.Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections.The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone.The world's microbiology laboratories can be a global microbial sensor network.Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus.Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131"Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract"SSTAR, a Stand-Alone Easy-To-Use Antimicrobial Resistance Gene Predictor.Diarrhea, bacteremia and multiorgan dysfunction due to an extraintestinal pathogenic Escherichia coli strain with enteropathogenic E. coli genes.
P2860
Q27000929-A8B915CC-F3F3-482E-8D57-99071C7508BDQ27011287-86E0952B-FBAF-4E9F-992D-7F7A30A959E5Q27013639-AFA313D6-37F4-4EE5-9998-3EBFA94900BEQ27325713-8E25ED14-0B47-4BD5-B3BE-31C24D69BC81Q30300020-FEB0F106-AE0E-4C51-BD2F-7944B474B0F2Q30378612-23D150CA-AD67-48E2-8DF4-556388697520Q30385057-72DDC27B-11C0-4A61-981D-A69E5A2A251CQ30386217-AB262943-4021-40F2-88C7-2666DD590EACQ30390256-943DA5B6-6FD9-4CB8-A375-4FCA478258DFQ30393531-B9BF1802-2F8D-4058-9564-8FBE8BC7E295Q30397339-C7C8F79E-97A7-42F7-9A0F-2E821A19FA11Q30401332-F438B523-19BB-47CD-8501-17E9FBDC3DBBQ30402829-982BD660-AA95-4A97-AFDA-FCC00F00797EQ31153565-DC06B0F8-9205-463E-A721-40FA9D979585Q33798233-1E9BD696-9B3E-41B3-B26B-C3848397E86DQ33798438-6B9ACD40-E372-47EB-9561-7BC6A0FA7ACCQ33798509-FAD61414-9A20-499E-A740-C115CAF5E1FEQ33806382-E5BE4D55-3BC6-415B-BFEF-215331253902Q34057648-959D4791-4854-45B5-99CD-67A254D7F8EAQ34426812-CBEBDAD6-A250-4A33-8C76-4BE02E81E18EQ34465192-4FE45875-ECE1-4AD8-B1E3-64408E5F49DEQ34593405-D23CA5FB-B7DA-4830-950E-6769ED9EA186Q34596560-7837E30B-4E11-439E-AF80-0536AF0C4DC4Q34596687-8C444148-D2AD-4E67-8BB3-A0B0A07BD74DQ34596717-B04038C9-3BFF-401A-8652-6C9E032AE1E0Q34732534-1415ACC1-62C6-4319-A3D0-E5E52A6D2711Q34916386-EDBE93ED-13DB-40FA-AA8E-29A0ADB69A20Q35008859-E432F97F-D006-4F41-A719-CFBA343B01BAQ35091026-9B53556D-8197-4487-9418-36C075557350Q35289728-219ADEAB-84A0-442F-8BBE-1A8AE749F0D6Q35443757-904DBFA1-030A-4416-AA0A-A0D246C592E9Q35607916-87435C72-DE1B-40EF-9F31-577219F466B0Q35628250-359EA949-207A-4070-9D8B-EE520801EEF5Q35676675-2E72F7D4-77EB-4D76-8575-8722A2D71C81Q35847272-3C0C93ED-0356-4B8E-8935-E327BF3C4D8AQ35960847-4AEA2022-A30E-41C5-9EDA-58040F0942BDQ35975566-77BBCEAF-7297-47C0-95C4-9E84A236FDF5Q35986381-5D9FB744-16F8-4C43-B744-D21257ADF9C7Q36052636-C2C169DA-8065-4D15-88A3-E38051B09EF2Q36211859-628DF1E6-1527-45A5-97AE-507546232835
P2860
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@ast
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@en
type
label
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@ast
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@en
prefLabel
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@ast
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@en
P2093
P2860
P50
P356
P1476
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
@en
P2093
Ajit P Limaye
Ari Robicsek
Brad T Cookson
Brian Johnston
Carl Urban
Chitrita Debroy
Connie Clabots
Darren J Trott
David C Hooper
Delia Scholes
P2860
P304
P356
10.1093/INFDIS/JIS933
P407
P577
2013-01-03T00:00:00Z